Holen Sie sich die Stockscreener-App
49.45
1.91%
-0.906
Schlusskurs vom Vortag:
$50.36
Offen:
$48.94
24-Stunden-Volumen:
1.32M
Relative Volume:
0.53
Marktkapitalisierung:
$6.36B
Einnahmen:
$10.12M
Nettoeinkommen (Verlust:
$-280.49M
KGV:
-17.11
EPS:
-2.89
Netto-Cashflow:
$-188.51M
1W Leistung:
+6.05%
1M Leistung:
+6.72%
6M Leistung:
+63.09%
1J Leistung:
+22.10%
1-Tages-Spanne:
$47.98
$50.05
1-Wochen-Bereich:
$45.24
$51.40
52-Wochen-Spanne:
$21.51
$56.00
Avidity Biosciences Inc Stock (RNA) Company Profile
Firmenname
Avidity Biosciences Inc
Sektor
Branche
Telefon
858-401-7900
Adresse
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Vergleichen Sie RNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNA
Avidity Biosciences Inc
|
49.44 | 6.48B | 10.12M | -280.49M | -188.51M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.77 | 101.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.00 | 59.25B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.81 | 60.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
762.03 | 45.95B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.25 | 37.61B | 3.81B | -644.79M | -669.77M | -6.24 |
Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-06-24 | Eingeleitet | Bernstein | Outperform |
| 2025-06-17 | Eingeleitet | Wolfe Research | Outperform |
| 2025-06-11 | Eingeleitet | Raymond James | Strong Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-09-24 | Eingeleitet | Goldman | Buy |
| 2024-08-28 | Eingeleitet | Barclays | Overweight |
| 2024-05-03 | Eingeleitet | BofA Securities | Buy |
| 2024-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-07-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-07-12 | Eingeleitet | Raymond James | Strong Buy |
| 2021-09-07 | Eingeleitet | Evercore ISI | Outperform |
| 2021-06-17 | Eingeleitet | Needham | Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | Credit Suisse | Outperform |
| 2020-07-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-07 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Avidity Biosciences Inc Aktie (RNA) Neueste Nachrichten
Why is Avidity Biosciences Inc. stock going upLayoff News & Weekly Setup with High ROI Potential - beatles.ru
Avidity Biosciences’ Phase 3 Study on AOC 1020: A Potential Breakthrough for FSHD - TipRanks
Avidity Biosciences’ Promising Phase 3 Study on Del-desiran for DM1: What Investors Need to Know - TipRanks
How to integrate Avidity Biosciences Inc. into portfolio analysis toolsProduct Launch & Fast Momentum Entry Tips - Newser
Is Avidity Biosciences Inc. stock ready for a breakoutJuly 2025 Summary & Daily Price Action Insights - Newser
Should you avoid Avidity Biosciences Inc. stock right nowJuly 2025 Earnings & Precise Swing Trade Alerts - خودرو بانک
Avidity Biosciences CEO Boyce sells $2.5 million in stock By Investing.com - Investing.com Canada
Avidity Biosciences: Chief commercial officer sells $308k in stock By Investing.com - Investing.com Canada
Sentiment analysis tools applied to Avidity Biosciences IncCEO Change & Free AI Powered Buy and Sell Recommendations - Newser
Volume spikes in Avidity Biosciences Inc. stock – what they meanMarket Movers & Safe Entry Point Alerts - Newser
Can Avidity Biosciences Inc. recover in the next quarterWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Avidity Biosciences shares rise 3.80% intraday after presenting at Cantor Global and Wells Fargo conferences. - AInvest
Take Profit: Can Avidity Biosciences Inc. outperform under higher oil pricesMarket Activity Report & Expert Verified Stock Movement Alerts - خودرو بانک
Avidity Biosciences: Pioneering RNA Therapeutics in the Race for Rare Disease Leadership - AInvest
Avidity Biosciences: Pioneering Precision in Gene Therapy with AOC Platform - AInvest
Transcript : Avidity Biosciences, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 12 - MarketScreener
Using Python tools to backtest Avidity Biosciences Inc. strategies2025 Key Lessons & AI Driven Price Predictions - Newser
Is Avidity Biosciences Inc. a top pick in the sector2025 Historical Comparison & Risk Managed Investment Entry Signals - خودرو بانک
Full technical analysis of Avidity Biosciences Inc. stockMarket Trend Summary & Consistent Income Trade Ideas - Newser
Is now a turning point for Avidity Biosciences Inc.Weekly Profit Report & Proven Capital Preservation Methods - Newser
Avidity Biosciences Inc. stock trend forecastJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
Technical Heatmap Flags Avidity Biosciences Inc. for WatchJuly 2025 Sector Moves & Community Verified Swing Trade Signals - beatles.ru
What’s the RSI of Avidity Biosciences Inc. stockJuly 2025 Technicals & Technical Entry and Exit Tips - خودرو بانک
Avidity Biosciences Inc. stock momentum explainedWeekly Profit Analysis & Technical Confirmation Alerts - Newser
Is Avidity Biosciences Inc. forming a reversal patternQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
News impact scoring models applied to Avidity Biosciences Inc.Analyst Downgrade & Risk Controlled Daily Plans - Newser
Price momentum metrics for Avidity Biosciences Inc. explainedJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Technical analysis overview for Avidity Biosciences Inc. stockWeekly Investment Summary & Low Risk High Reward Trade Ideas - Newser
Order flow analysis tools used on Avidity Biosciences Inc.July 2025 Setups & High Conviction Investment Ideas - Newser
Tools to monitor Avidity Biosciences Inc. recovery probabilityTrade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
Avidity Biosciences CPO sells $8914 in RNA stock By Investing.com - Investing.com South Africa
Avidity Biosciences CPO sells $8914 in RNA stock - Investing.com
Avidity Biosciences' Kathleen Gallagher Sells 188 Shares at $47.42 - AInvest
Arrowhead, Novartis in up to $2 billion deal for neuromuscular therapy license - Reuters
Is Avidity Biosciences Inc. stock showing strong momentumJuly 2025 Outlook & Capital Efficiency Focused Strategies - خودرو بانک
Reversal indicators forming on Avidity Biosciences Inc. stockEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
Detecting price anomalies in Avidity Biosciences Inc. with AIEarnings Recap Report & Weekly High Conviction Ideas - Newser
Can Avidity Biosciences Inc. outperform under higher oil pricesJuly 2025 News Drivers & Expert Approved Trade Ideas - خودرو بانک
How to use a screener to detect Avidity Biosciences Inc. breakouts2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Momentum Shift: Can Avidity Biosciences Inc. reach resistance levels soonQuarterly Profit Summary & Reliable Price Breakout Alerts - خودرو بانک
Short Covering: Is Avidity Biosciences Inc. stock a top performer YTD2025 Price Momentum & AI Powered Trade Plan Recommendations - خودرو بانک
Analyzing recovery setups for Avidity Biosciences Inc. investorsPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
Published on: 2025-09-02 00:27:58 - خودرو بانک
Is Avidity Biosciences Inc. a potential multi baggerJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
RNA Stock Price and Chart — NASDAQ:RNA - TradingView
What moving averages say about Avidity Biosciences Inc.July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Does Avidity Biosciences Inc. show high probability of reboundWeekly Trend Summary & Safe Entry Point Alerts - Newser
Published on: 2025-08-31 20:59:49 - Newser
Finanzdaten der Avidity Biosciences Inc-Aktie (RNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avidity Biosciences Inc-Aktie (RNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Boyce Sarah | President and CEO |
Sep 05 '25 |
Sale |
49.95 |
50,000 |
2,497,435 |
305,871 |
| Mosbrooker Eric | Chief Commercial Officer |
Sep 03 '25 |
Option Exercise |
9.05 |
6,563 |
59,395 |
61,563 |
| Mosbrooker Eric | Chief Commercial Officer |
Sep 03 '25 |
Sale |
47.07 |
6,563 |
308,936 |
55,000 |
1.08%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):